LENZ Therapeutics, Inc. (LENZ) Executive Compensation
LENZ Therapeutics, Inc. (LENZ) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LENZ
CIK: 1815776
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerCasey Hayes
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0000315066-26-002292 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001815776-26-000052 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001815776-26-000051 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | 8-K | 0001815776-26-000046 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-26 | — | SCHEDULE 13G Filing | 0001104659-26-078313 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | 4 Filing | 0001231919-26-000640 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | FORM 4 | 0001796789-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | FORM 4 | 0001340881-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | FORM 4 | 0001200889-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | FORM 4 | 0001297491-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | FORM 4 | 0001825009-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | FORM 4 | 0001816523-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-12 | 8-K | 0001815776-26-000041 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001815776-26-000037 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001815776-26-000035 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001815776-26-000029 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001815776-26-000028 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-06-12 | DEF 14A | 0001815776-26-000026 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-27 | — | SCHEDULE 13G Filing | 0002012383-26-001701 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-08 | — | SCHEDULE 13G Filing | 0001642575-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-27 | FORM 4 | 0001796789-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-27 | FORM 4 | 0001713795-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-27 | FORM 4 | 0001706176-26-000004 | View SEC Doc Filr Page |
| S-8 | 2026-03-24 | — | S-8 | 0001815776-26-000013 | View SEC Doc Filr Page |
| 10-K | 2026-03-24 | 2025-12-31 | 10-K | 0001815776-26-000011 | View SEC Doc Filr Page |